Home
About
Overview
Sharing Data
ORCID
Help
History (35)
Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.
Emblems and Insignia
A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity.
Perinatal deiodinase 2 expression in hepatocytes defines epigenetic susceptibility to liver steatosis and obesity.
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer.
See All 35 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer.
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
View in:
PubMed
subject areas
Biomarkers, Tumor
Early Detection of Cancer
Humans
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor I
Lung Neoplasms
Mass Screening
Prognosis
authors with profiles
Michael J Liptay
Jeffrey Allen Borgia
Christopher W Seder